Durect corp

Financial Times Close. Search the FT Search. Show more World link World.

DURECT harnesses epigenetic modulation to treat serious and life-threatening conditions, including acute organ injury and cancer. Many types of acute organ injuries and cancers are associated with dysregulation of the epigenome, such as DNA methylation. There is vast potential for epigenetic therapies to address the underlying pathophysiology by mitigating epigenomic dysregulation and helping to improve cellular function or suppress tumor growth. Join our highly experienced, talented, and collaborative team as we strive to improve the course of human medicine with novel epigenetic therapies. Brown, President and Chief. Unlocking the potential of epigenetic therapeutics to revolutionize medicine. Epigenetic Modulation.

Durect corp

.

Save Clear.

.

Brown , D. In conjunction with teams of experienced chemists and biologists, our research and development team have designed new chemical entities NCE that are now in preclinical development for multiple oncology indications. With this achievement, DURECT is advancing its mission to be a global leader in the emerging field of epigenetic medicine. Earnings Conference Call We will host a conference call and webcast today at p. Pacific Time to discuss second quarter results and provide a corporate update:. Wednesday, August 9 p. Participants can use guest dial-in numbers above to reach an operator or they can click the Call me TM link for instant telephone access to the event dial-out. The Call me TM link will be made active 15 minutes prior to scheduled start time.

Durect corp

The closing of the Offering is expected to occur on or about July 21, , subject to customary closing conditions. DURECT intends to use the net proceeds of the Offering for general corporate purposes, which may include clinical trials, research and development activities, capital expenditures, selling, general and administrative costs, facilities expansion, and to meet working capital needs. The Offering is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. The prospectus supplement and the accompanying prospectus relating to, and describing the terms of, the Offering will be filed with the SEC. Alternatively, copies of the prospectus supplement and accompanying prospectus can be obtained, when available, from H.

Softwilly

Epigenetic dysregulation in cardiovascular aging and disease. Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. We also use third-party cookies that help us analyze and understand how you use this website. You also have the option to opt-out of these cookies. Press Releases. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities. Join our highly experienced, talented, and collaborative team as we strive to improve the course of human medicine with novel epigenetic therapies. This cookie is set by Rubicon Project to control synchronization of user identification and exchange of user data between various ad services. Use our equities screener to discover other potential opportunities. The cookie is used to store the user consent for the cookies in the category "Analytics". Analytical cookies are used to understand how visitors interact with the website. Scroll to Top. Cookie Duration Description c 6 months 2 days This cookie is set by Rubicon Project to control synchronization of user identification and exchange of user data between various ad services.

The pre-funded warrants and the accompanying warrants will be immediately exercisable. The pre-funded warrants do not expire and the accompanying warrants will expire five years from the date of issuance. The closing of the Offering is expected to occur on or about February 8, , subject to customary closing conditions.

Partner with us. DURECT harnesses epigenetic modulation to treat serious and life-threatening conditions, including acute organ injury and cancer. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". These cookies ensure basic functionalities and security features of the website, anonymously. All markets data located on FT. Show more Markets link Markets. This cookie is used by the website's WordPress theme. Price USD 0. Add to Your Portfolio New portfolio. Show more Tech link Tech. It allows the website owner to implement or change the website's content in real-time.